Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2025

Nov 12, 2025

284_dirs_2025-11-12_5522f408-34bb-4f6c-a2e5-9308525b1381.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-11-10

Reporting Person: Downing Cristal N (Chief Comm. & Public Afrs Ofcr)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-10 Common Stock S 7085 $87.00 Disposed 0 Direct